Five years ago the country's first national lockdown began. Now, as Ebola, Mpox and bird flu are deemed 'high risk', experts ...

The narratives that have grown around pandemic lockdowns have increasingly supplanted any tales of the ingenuity, dedication, ...

NIH has launched a human trial for LASSARAB, a dual-purpose vaccine targeting Lassa fever and rabies. Early animal studies ...

A decade after the worst of the virus’ 40 outbreaks killed 11,300 people, individuals who still bear its physical and mental ...

The NIH announced the beginning of a phase 1 first-in-human trial of a vaccine for Lassa fever, a potentially fatal viral hemorrhagic disease for which there is no approved vaccine or treatment.

The chikungunya vaccination is recommended for those traveling to areas where there is a chikungunya outbreak.

A study has found that a single dose of the Imvanex vaccine provides protection against Mpox with 84% effectiveness. For people with HIV, however, a single dose of the vaccine fails to offer ...

The Oropouche virus has been linked to Zika-like outcomes in pregnant people, with cases more than doubling in 2024 ...

Health workers comb affected districts for remnant cases NEWS ANALYSIS | RONALD MUSOKE |  Uganda’s Ministry of Health ...

A medical epidemiologist explains who should consider getting a booster and whether you might need to check your antibody ...

Can the continent walk the talk? **** The African Union has embarked on one of its most audacious health security missions: ...

Five years after Texas’ first COVID death, the state spends less on public health, vaccination rates have dropped and a distrust of authority has taken hold.